Profile photo Tom Snijders

Tom Snijders

Associate Professor - medical

Strategic program(s):

Biography

T.J. (Tom) Snijders, PhD, completed his medical studies and his Neurology residency in the UMC Utrecht. During his training, he obtained a PhD-degree in the field of chronic pain medicine. He sub-specialized in Neuro-oncology during his residency.

Since 2011, he works as a neurologist and assistant professor in the UMC Utrecht. His practice encompasses all aspects of neuro-oncological patient care. His scientific work focuses on primary brain tumors, specifically gliomas. He is the co-coordinator, with prof. Elly Hol, of the Disease Area Neuro-oncology of the UMC Utrecht Brain Center.  He is co-supervisor of 5 completed or ongoing PhD-trajectories. He is also involved in providing and evaluating experimental treatments (international clinical trials) in the UMC Utrecht.

Research interests:

  • Validation and innovation of imaging techniques for brain tumors, including MRI-scans and PET-scans
  • Pseudoprogression in glioma and other brain tumors
  • Cognitive symptoms in glioma patients
  • Epilepsy due to brain tumors
  • Liquid biopsy in primary brain tumors
  • Focused Ultrasound and blood-brain-barrier disruption for brain tumor treatment
  • The multidisciplinary Team Neuro-Oncology of the UMC Utrecht aims to provide patients with the most recent innovative (experimental) treatments for brain tumors as part of clinical studies.

Research groups

Clinical and translational neuro-oncology

Research aim

We aim to improve treatments and clinical outcomes of patients with gliomas and other brain tumors, by combining expertise from oncobiology, neuropsychology, imaging, surgical & clinical neurology, and palliative care.

Go to group

Recent publications

Patient perspectives on diagnostic uncertainty and novel diagnostic tests in neuro-oncology Veerle J. Ruijters, Marloes M. Bauer, Nelleke Tolboom, Tatjana Seute, Leonie N.C. Visser, Tom J. Snijders
Neuro-Oncology Practice, 2026, vol. 13, p.733-742
Exploring brain-glioma interaction Eva A Krijnen, Emma van Kessel, Angelika Mühlebner, Sven van Kempen, Wim Van Hecke, Martine J E van Zandvoort, Pierre A Robe, Tom J Snijders
Neuro-oncology advances, 2026, vol. 8
Diagnosis of primary CNS lymphoma through molecular and immune biomarkers in cerebrospinal fluid (PRICELUS) Josephus L M van Rooij, Peter H Wessels, Johanna M Niers, Jacoline E C Bromberg, Johanna M M Gijtenbeek, Rick van Haastert, Henk J T Ruven, Bob Meek, Marcel M Verbeek, Nienke Solleveld-Westerink, Wendy W J de Leng, Angelika Mühlebner, Anton W Langerak, Sharon Berendsen, Edward F Knol, Hanna van Alkemade, Tatjana Seute, Monique C Minnema, Stefan Nierkens, Tom J Snijders
The Lancet. Haematology, 2026, vol. 13, p.e376-e385
Postoperative ischemia and neurological deficits after glioma resection Arthur T.J. van der Boog, Eva E. van Grinsven, Matea Rados, Tom J. Snijders, Joost J.C. Verhoeff, Pierre A. Robe
Neuro-Oncology Practice, 2026, vol. 13, p.452-464
Understanding the unmet needs of patients with brain metastases referred for stereotactic radiotherapy and their caregivers Fia Cialdella, Eva E van Grinsven, Steven H J Nagtegaal, Arthur T J van der Boog, Celeste C Hinkert, Marion G Jentink, Ernst J Smid, An Claes, Catharina E Kleynen, Tom J Snijders, Filip Y F de Vos, Marielle E P Philippens, Martine J E van Zandvoort, Szabolcs David, Joost J C Verhoeff
Neuro-Oncology Practice, 2026, vol. 13, p.262-275
Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG) A M de Jong, A T J van der Boog, C C B Post, F Cialdella, D B P Eekers, J Hendrikse, M C A Kramer, F J Lagerwaard, M van der Meulen, M E P Philippens, P A Robe, T Rozema, F Y F L de Vos, J Vos-Westerman, H L van der Weide, G Wester, J Zindler, T J Snijders, J J C Verhoeff
PLoS ONE, 2026, vol. 21

External positions

editorial board member - editorial work & peer review - Neuro Oncology Practice

reviewer board member - peer review - MDPI Cancers (Basel)

member (ongoing), steering committee member (2021-2024), imaging committee member (2018-2024), - organization and planning of scientific research - EORTC Brain Tumor group

Committee Member - richtlijn opstellen/onderhouden - Task Force on Bing Neel Syndrome

Guideline committee ‘Intracranial meningioma', member (2012-2015), chairperson (since 2023) - writing a guideline, leading the team - Kennisinstituut/NVN

Chairperson/chief (until 2023), member (since 2023) - writing and editing medical information on website; answering questions from kanker.nl - Editorial board (‘redactieraad’) of Hersentumor.nl